Conversations in Drug Development podcast

EU Device Reform: What MDR & IVDR Changes Mean for Innovators

0:00
28:27
Rewind 15 seconds
Fast Forward 15 seconds

This episode unpacks the European Commission’s December 2025 proposal to amend the EU Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR). Eric Hardter and Eamonn McGowran from Boyds review key reforms - simplification and proportionality, reduced administrative burden, support for breakthrough and orphan devices, better EU coordination, digitalization, and increased EMA involvement - and explain what these changes could mean for manufacturers, small developers, and patient access.

More episodes from "Conversations in Drug Development"